Sickle Cell

Two factors commonly used to evaluate patients with sickle cell disease are associated with each other and can predict increased mortality, Vanderbilt researchers have discovered. Read More

Vanderbilt University Medical Center is part of a 6-year, $4.4 million grant from the National Institutes of Health to improve the use of prescribed medication by sickle cell patients. Read More

Community Research Partners will present the Tennessee Sickle Cell Disease Network on Friday, Sept. 2, from 8:30 to 10 a.m. at the Matthew Walker Comprehensive Health Center, 1035 14th Ave. N. Read More

Naazariah Thomas and her mom, Marissa, make the trek from Clarksville to Nashville every two months because the customized, comprehensive health care the toddler needs is not available in her hometown. Naazariah has sickle cell disease, an inherited blood disorder that affects the red blood cells. The disease can cause… Read More

Vanderbilt-led research found regular blood transfusion therapy significantly reduces the recurrence of strokes in children with sickle cell anemia who have previously had "silent" strokes. Read More

The Levi Watkins Jr. Lecture will be held Oct. 14, featuring keynote speaker Michael R. DeBaun. Read More

Michael R. DeBaun, M.D., MPH, has been recognized by the American Society of Hematology (ASH) for his significant contributions and research advances in the area of sickle cell disease. Read More

Researchers from the Monroe Carell Jr. Children’s Hospital at Vanderbilt and Aminu Kano Teaching Hospital in Kano, Nigeria, will work on a collaborative project to study a sickle cell disease treatment for children in Nigeria. Read More

Dr. Michael R. DeBaun, vice chair for Clinical Research for Vanderbilt’s Department of Pediatrics, has received a $1.4 million grant from the Health Resource and Services Administration (HRSA) for the new Vanderbilt, Meharry, Matthew Walker Center for Sickle Cell Disease Excellence. Read More